tiprankstipranks
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market

Edgewise Therapeutics (EWTX) Financial Statements

126 Followers

Edgewise Therapeutics Financial Overview

Edgewise Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.535; its P/E ratio is -11.91; Edgewise Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -34.75M$ -33.86M$ -25.71M$ -21.47M$ -25.70M
EBITDA$ -34.23M$ -33.33M--$ -27.53M
Net Income Common Stockholders$ -28.52M$ -30.14M$ -25.71M$ -21.47M$ -22.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 532.76M$ 318.39M$ 289.70M$ 309.93M$ 327.95M
Total Assets$ 553.81M$ 340.04M$ 311.36M$ 330.63M$ 346.40M
Total Debt$ 5.25M$ 5.41M$ 5.53M$ 5.64M$ 5.64M
Net Debt$ -527.51M$ -312.98M$ -284.17M$ -304.29M$ -322.31M
Total Liabilities$ 18.86M$ 21.20M$ 20.94M$ 19.17M$ 17.56M
Stockholders Equity$ 534.93M$ 318.83M$ 290.43M$ 311.46M$ 328.84M
Cash Flow-
Free Cash Flow$ -28.89M$ -26.99M--$ -27.19M
Operating Cash Flow$ -28.60M$ -26.83M$ -22.06M-$ -22.82M
Investing Cash Flow$ -268.31M$ 26.98M$ 23.42M-$ 49.04M
Financing Cash Flow$ 241.07M$ 52.99M$ -211.00K-$ 21.00K
Currency in USD

Edgewise Therapeutics Earnings and Revenue History

Edgewise Therapeutics Debt to Assets

Edgewise Therapeutics Cash Flow

Edgewise Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis